Market Tracker

09/26 5:16pm ET

Abiomed Inc (NASDAQ:ABMD)

126.72
Delayed Data
As of 3:59pm ET
 +3.19 / +2.58%
Today’s Change
67.81
Today|||52-Week Range
127.86
+40.36%
Year-to-Date
Nevro Hits New 52-Week High on Solid HF10 Therapy Sales
9:41am / Zacks.com - Paid Partner Content
CryoLife Hits a 52-Week High on Strong Growth Prospects
Sep 23 / Zacks.com - Paid Partner Content
Patterson Companies Faces Multiple Issues: Dump Now?
9:41am / Zacks.com - Paid Partner Content
Thermo Fisher Adds FEI Co., Inorganic Expansion Continues
Sep 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close123.53
Today’s open123.25
Day’s range122.26 - 127.22
Volume429,545
Average volume (3 months)508,859
Market cap$5.3B
Dividend yield--
Data as of 3:59pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)-67.92%
Earnings growth (this year)+37.91%
Earnings growth (next 5 years)+27.50%
Revenue growth (last year)+43.09%
P/E ratio134.8
Price/Sales12.92
Price/Book14.27

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...-0.76-1.05%
CMNCantel Medical Corp-0.85-1.05%
NUVANuVasive Inc-0.62-0.93%
IARTIntegra LifeSciences...-1.20-1.38%
Data as of 4:02pm ET, 09/26/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)$0.24
Annual revenue (last year)$329.5M
Annual profit (last year)$38.1M
Net profit margin11.58%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts